IM Cannabis Corp. 6-K Filing

From the Filing

0001178913-25-003674.txt : 20251106 0001178913-25-003674.hdr.sgml : 20251106 20251106071701 ACCESSION NUMBER: 0001178913-25-003674 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20251106 FILED AS OF DATE: 20251106 DATE AS OF CHANGE: 20251106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 251456140 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533943.htm 6-K   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of November 2025   (Report No. 1) .   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒   Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____   Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____   Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.   SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.       IM CANNABIS CORP.     (Registrant)         Date: November 6, 2025 By: /s/ Oren Shuster     Name: Oren Shuster     Title: Chief Executive Officer and Director   EXHIBIT INDEX   99.1 News Release dated November 6, 2025 EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 IM Cannabis to Report third Quarter 2025 Financial Results on Thursday, November 13 th at 9:00am ET   TORONTO and GLIL YAM, Israel, November 6, 2025/CNW/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the " Company ", " IMCannabis ", or " IMC "), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third quarter 2025 ended September 30, 2025, on Thursday, November 13, 2025, before the market opens.   About IM Cannabis Corp.   IMC (Nasdaq: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company’s focus is to achieve susta